BackgroundAnaplastic Large Cell Lymphoma (ALCL) is one of the most common subtypes of T-cell lymphoma. Among these. refractory and relapsed (r/r) ALK positive ALCL lacks effective therapies. The chimeric antigen receptor-modified T (CAR-T) cell therapy holds great promise as a therapeutic strategy for this disease. https://www.nacrack.com/mega-pick-As-for-Me-and-My-House-Wall-Decal-in-Hebrew-Yahauh-flash-find/